• Clazakizumab ELISA Kit
1 1

AntibodySystem

KDC15801

Clazakizumab ELISA Kit

Clazakizumab ELISA Kit

Title

Catalog No.: KDC15801

Catalog No. KDC15801
Product name Clazakizumab ELISA Kit
Size 96 T
Description PRINCIPLE OF THE ASSAY This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant Human IL6 has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any Clazakizumab present is bound by the immobilized protein. After washing away any unbound substances, a biotin-labeled Mouse Anti-Human IgG antibody is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Clazakizumab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications Used for the quantitative determination of Clazakizumab concentration in serum and plasma.
Stability and Storage When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Detection method Colorimetric
Precision CV<15%
Sample type Plasma, Serum
Assay type Quantitative
Sensitivity 0.54 ng/mL
Range 1.56 - 100 ng/mL
Recovery 80-120%
Background Clazakizumab, a humanized anti–IL-6 mAb, is used in the phase II clinical trial for the treatment of RA patients. It has also been evaluated for the treatment of non-small cell lung cancer (NSCLC) and patients with head and neck cancer.
Alternative Names ALD-518, BMS-945429, CAS: 1236278-28-6
Shipping 2-8 ℃
Note For Research Use Only.
전체 세부 정보 보기